Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shree Ganesh Biotech (India) has a quick ratio of 1.01. It generally indicates good short-term financial strength.
The historical rank and industry rank for Shree Ganesh Biotech (India)'s Quick Ratio or its related term are showing as below:
BOM:539470'
s Quick Ratio Range Over the Past 10 Years
Min: 0.35 Med: 1.95 Max: 688.49
Current: 1.01
During the past 12 years, Shree Ganesh Biotech (India)'s highest Quick Ratio was 688.49. The lowest was 0.35. And the median was 1.95.
BOM:539470's Quick Ratio is ranked worse than 50.19% of 259
companies
in the Agriculture industry
Industry Median: 1.01
vs BOM:539470: 1.01
Shree Ganesh Biotech (India) (BOM:539470) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Shree Ganesh Biotech (India) Quick Ratio Related Terms
Shree Ganesh Biotech (India) Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539470 vs CTVA, CF, MOS: Quick Ratio Comparison
For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Ganesh Biotech (India) Quick Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Quick Ratio distribution charts can be found below:
* The bar in red indicates where Shree Ganesh Biotech (India)'s Quick Ratio falls into.
Shree Ganesh Biotech (India) Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Ganesh Biotech (India) (BOM:539470) has a Quick Ratio of 1.01 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shree Ganesh Biotech (India) and its competitors. This is 48% below median its historical median of 1.95. Over the past decade, Shree Ganesh Biotech (India)'s Quick Ratio has ranged from 0.35 to 688.49. According to the industry distribution chart, Shree Ganesh Biotech (India) ranks #130 out of 259 companies in the Agriculture industry, placing it in the top 50.2%.
Is Shree Ganesh Biotech (India)'s Quick Ratio too high?
Shree Ganesh Biotech (India)'s current Quick Ratio of 1.01 is 48% below median its 10-year median of 1.95. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 688.49. The Agriculture industry median Quick Ratio is 1.01. Shree Ganesh Biotech (India)'s value of 1.01 is 0% at this industry median. Based on the distribution chart, Shree Ganesh Biotech (India) ranks #130 out of 259 companies in the Agriculture industry, which is below the industry midpoint. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s Quick Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shree Ganesh Biotech (India) ranks #130 out of 259 companies for Quick Ratio. This places Shree Ganesh Biotech (India) in the lower half of its industry. The industry median Quick Ratio is 1.01. Shree Ganesh Biotech (India)'s value of 1.01 is 0% at this benchmark. Historically, Shree Ganesh Biotech (India)'s own Quick Ratio has ranged from 0.35 to 688.49 over the past decade. While the company's 10-year median is 1.95 vs. the industry median of 1.01, Shree Ganesh Biotech (India) has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for an Agriculture company?
The median Quick Ratio among Agriculture companies is 1.01, based on 259 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shree Ganesh Biotech (India)'s current Quick Ratio of 1.01 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shree Ganesh Biotech (India) and its competitors. For the Agriculture industry, the median Quick Ratio is 1.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Ganesh Biotech (India)'s current Quick Ratio is 1.01, which is 48% below median its own 10-year median of 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.19, compared to a current price of ₹0.55 — trading 189.5% above its estimated fair value. The current Quick Ratio is 1.01, which is 48% below median its 10-year median of 1.95 and 0% at the Agriculture industry median of 1.01. Shree Ganesh Biotech (India)'s overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current Quick Ratio is 1.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued.
The current stock price of ₹0.55 is trading 189.5% above its estimated GF Value™ of ₹0.19.
GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.
Key valuation signals for BOM:539470:
Quick Ratio: 1.01 (48% below median its 10-year median of 1.95)
GF Value™: ₹0.19 vs. price of ₹0.55 (189.5% above fair value)
Industry Position: 0% at the Agriculture median (#130 of 259)
No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
46GF Score
Get the complete analysis for BOM:539470
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539470 has been successfully added to your 
